<DOC>
	<DOCNO>NCT00265993</DOCNO>
	<brief_summary>Study objective : - To evaluate efficacy/safety profile enoxaparin day treatment acute venous thromboembolic disease .</brief_summary>
	<brief_title>Enoxaparin Acute Venous Thromboembolic Disease</brief_title>
	<detailed_description />
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<mesh_term>Thromboembolism</mesh_term>
	<criteria>Patients symptomatic lowerextremity deep venous thrombosis confirm doppler USG ( ultrasonography ) , without confirm symptomatic pulmonary embolism associate provoked risk factor Patients history heparin warfarin treatment longer 24 hour , Patients require thrombolytic treatment , Patients thrombophilia diagnosis , Patients prior deep vein thrombosis pulmonary embolus evidence , Patients familial bleeding disorder , Patients know bleeding risk , active bleeding , active ulcerative bowel disease , angiodysplasia oculary , spinal central nervous system surgery within last month Patients renal failure ( serum creatinine concentration &gt; 180 mmol/L &gt; 2.03 mg/dL ) , Patients severe hepatic failure Patients history allergy heparin protamine , Patients history thrombocytopenia associate heparin administration skin necrosis heparin warfarin treatment , Patients participate another clinical study within last 4 month Patients pregnant The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2010</verification_date>
</DOC>